{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:45:52Z","timestamp":1775202352587,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional De Promocion Cientifica Y Tecnologica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127045","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:52:59Z","timestamp":1743742379000},"page":"127045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II\/III, randomized clinical trial"],"prefix":"10.1016","volume":"54","author":[{"given":"Gonzalo","family":"Perez Marc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena M.","family":"Coria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica E.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"P\u00e1ez C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara G.","family":"Fascetto Cassero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Rios Medrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Fulgenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda F.","family":"Alzogaray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anal\u00eda","family":"Mykietiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio Leandro","family":"Uriarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Itcovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"Smith Casabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n A.","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo A.","family":"Yerino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Braem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anal\u00eda","family":"Christmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Corradetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn C.","family":"Darraidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucila","family":"Di Nunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"L\u00f3pez Castelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Marchionatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucila","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgina","family":"Trias Uriarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Zadoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Bues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Manenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina A.","family":"Del Priore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s C.","family":"Hernando Insua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid G.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Di Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Gongora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustin","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Cervellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Toneguzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostina","family":"Demar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lineia","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Pueblas Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Saposnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Geffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Montes de Oca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio C.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Fl\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Bonveh\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cassar\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina A.","family":"Pasquevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Cassataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127045_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1544","article-title":"The WHO has declared the end of pandemic phase of COVID-19: way to come back in the normal life","volume":"6","author":"Sarker","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127045_bb0010","author":"Statement on the fifteenth meeting of the IHR"},{"key":"10.1016\/j.vaccine.2025.127045_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X241228053","article-title":"The WHO has declared COVID-19 is no longer a pandemic-level threat: a perspective evaluating potential public health impacts","volume":"17","author":"Roknuzzaman","year":"2024","journal-title":"Clin Pathol"},{"key":"10.1016\/j.vaccine.2025.127045_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of protection against mild and severe disease by Covid-19 vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","article-title":"COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection","volume":"29","author":"Chi","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2025.127045_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032264","article-title":"Convergent evolution in SARS-CoV-2 spike creates a variant soup from which new COVID-19 waves emerge","volume":"24","author":"Focosi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2025.127045_bb0035","article-title":"Relative effectiveness and waning of a third dose of mRNA COVID-19 vaccine in Medicare beneficiaries aged 65 years and older during the BA.1\/BA.2 omicron period","author":"Lu","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0040","series-title":"SAGE Roadmap for prioritizing uses of COVID-19 vaccines","author":"WHO","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127045_bb0045","first-page":"9","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","author":"Uddin","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127045_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008548","article-title":"Developing a low-cost and accessible COVID-19 vaccine for global health","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pbiomolbio.2023.02.004","article-title":"An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines","volume":"178","author":"Bayani","year":"2023","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.vaccine.2025.127045_bb0060","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1016\/j.vaccine.2022.09.064","article-title":"With established safe and effective use, protein vaccines offer another choice against COVID-19","volume":"40","author":"Marchese","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127045_bb0065","article-title":"Disposition DI-2023-8604-APN-ANMAT#MS. National administration of drugs","author":"ANMAT","year":"2023","journal-title":"Food Med Dev"},{"key":"10.1016\/j.vaccine.2025.127045_bb0070","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41467-024-45180-8","article-title":"A gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection","volume":"15","author":"Coria","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127045_bb0075","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1038\/s41467-023-40272-3","article-title":"Safety and immunogenicity of a SARS-CoV-2 gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults","volume":"14","author":"Pasquevich","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127045_bb0080","series-title":"WHO manual for the establishment of national and other secondary standards for antibodies against infectious agents focusing on SARSCoV2","author":"World_Health_Organization","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127045_bb0085","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0090","article-title":"Guidance For industry: Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials","author":"FDA","year":"2007","journal-title":"Food Drug Admin. US Department of Health and Human Services."},{"key":"10.1016\/j.vaccine.2025.127045_bb0095","series-title":"Underlying conditions and the higher risk for severe COVID-19","author":"CDC","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127045_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102109","article-title":"Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant AS a booster in adults primed with authorized vaccines: a phase 3, parallel-group study","volume":"62","author":"de Bruyn","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127045_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(24)00077-X","article-title":"Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial","volume":"24","author":"Bennett","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0110","article-title":"Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial","volume":"28","author":"Corominas","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2025.127045_bb0115","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/infdis\/jiad508","article-title":"Immunogenicity and safety of heterologous omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3 randomized clinical trial","volume":"230","author":"Bennett","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104878","article-title":"Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster","volume":"98","author":"Nolan","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127045_bb0125","series-title":"Vacunas contra el SARS-CoV-2 (SARS-CoV-2 vaccines authoized in Argentina) https:\/\/www.argentina.gob.ar\/anmat\/covid-19-acciones\/vacunas: argentina.gocv. Ar","author":"ANMAT","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127045_bb0130","article-title":"Heterologous prime-boost strategies for COVID-19 vaccines","volume":"29","author":"Sapkota","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127045_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191710752","article-title":"Comparison of the effectiveness and safety of heterologous booster doses with homologous booster doses for SARS-CoV-2 vaccines: a systematic review and Meta-analysis","volume":"19","author":"Deng","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2025.127045_bb0145","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41591-023-02517-y","article-title":"Original SARS-CoV-2 monovalent and omicron BA.4\/BA.5 bivalent COVID-19 mRNA vaccines: phase 2\/3 trial interim results","volume":"29","author":"Chalkias","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2213907","article-title":"Antibody response to omicron BA.4-BA.5 bivalent booster","volume":"388","author":"Wang","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(23)00181-0","article-title":"SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster","volume":"23","author":"Wang","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0160","doi-asserted-by":"crossref","first-page":"1401209","DOI":"10.3389\/fimmu.2024.1401209","article-title":"Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an omicron BA.4\/BA.5- specific response","volume":"15","author":"Baker","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127045_bb0165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0170","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41586-024-07539-1","article-title":"Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines","volume":"630","author":"Liang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127045_bb0175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41541-021-00393-6","article-title":"Scientific rationale for developing potent RBD-based vaccines targeting COVID-19","volume":"6","author":"Kleanthous","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127045_bb0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0185","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.vaccine.2023.05.051","article-title":"Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373","volume":"41","author":"Alves","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127045_bb0190","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1473-3099(23)00295-5","article-title":"Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial","volume":"23","author":"Lee","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0195","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/cid\/ciad718","article-title":"A bivalent omicron-BA.4\/BA.5-adapted BNT162b2 booster in >\/=12-year-olds","volume":"78","author":"Usdan","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127045_bb0200","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A bivalent omicron-containing booster vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127045_bb0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7774\/cevr.2021.10.2.171","article-title":"Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country","volume":"10","author":"Al-Mistarehi","year":"2021","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2025.127045_bb0210","first-page":"344","article-title":"COVID-19 vaccine hesitancy and early adverse events reported in a cohort of 7,881 Italian physicians","volume":"34","author":"Monami","year":"2022","journal-title":"Ann Ig"},{"key":"10.1016\/j.vaccine.2025.127045_bb0215","article-title":"Summary of product characteristics","author":"EMA","year":"2025","journal-title":"Comirnaty Omicron XBB.1.5"},{"key":"10.1016\/j.vaccine.2025.127045_bb0220","article-title":"Summary of product characteristics","author":"EMA","year":"2025","journal-title":"Spikevax"},{"key":"10.1016\/j.vaccine.2025.127045_bb0225","first-page":"15","article-title":"Research advances on the stability of mRNA vaccines","author":"Cheng","year":"2023","journal-title":"Viruses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:41:28Z","timestamp":1762278088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25003421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":45,"alternative-id":["S0264410X25003421"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II\/III, randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127045"}}